Location: Home » Publications
 Last updated: 7-24-2007
   
Search


Menu

You are not logged in [Login]

Full text of selected relevant publications

  1. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P.
    Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.
    Lancet. 2006 Feb 4;367(9508):404-11.  
  2. Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, Mak R, Keyzers KC, Buller HR.
    Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.
    Lancet. 2000 Jul 8;356(9224):97-102. 
  3. Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM.
    Self-management of oral anticoagulant therapy: a systematic review and meta-analysis.
    Int J Cardiol. 2007 May 16;118(1):54-61. Epub 2006 Aug 7.  
  4. Siebenhofer A, Berghold A, Sawicki PT.
    Systematic review of studies of self-management of oral anticoagulation.
    Thromb Haemost. 2004 Feb;91(2):225-32.  
  5. Ansell JE.
    Empowering patients to monitor and manage oral anticoagulation therapy.
    JAMA. 1999 Jan 13;281(2):182-3.
  6. Fitzmaurice DA, Murray ET, Gee KM, Allan TF, Hobbs FD.
    A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.
    J Clin Pathol. 2002 Nov;55(11):845-9.
  7. Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, van den Besselaar AM, Sturk A, Rosendaal FR.
    Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial.
    Arch Intern Med. 2003 Nov 24;163(21):2639-46. 
  8. Gadisseur AP, Kaptein AA, Breukink-Engbers WG, van der Meer FJ, Rosendaal FR.
    Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life.
    J Thromb Haemost. 2004 Apr;2(4):584-91. 
  9. Sawicki PT.
    A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.
    JAMA. 1999 Jan 13;281(2):145-50. 
  10. Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B.
    A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Thromb Haemost. 2000 May;83(5):661-5.
  11. Fitzmaurice DA, Machin SJ; British Society of Haematology Task Force for Haemostasis and Thrombosis.
    Recommendations for patients undertaking self management of oral anticoagulation.
    BMJ. 2001 Oct 27;323(7319):985-9.
  12. Gardiner C, Williams K, Mackie IJ, Machin SJ, Cohen H.
    Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring.
    Br J Haematol. 2005 Jan;128(2):242-7.
  13. Gardiner C, Williams K, Longair I, Mackie IJ, Machin SJ, Cohen H.
    A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.
    Br J Haematol. 2006 Mar;132(5):598-603.
  14. Fitzmaurice DA, Murray ET, McCahon D, Holder R, Raftery JP, Hussain S, Sandhar H, Hobbs FD.
    Self management of oral anticoagulation: randomised trial.
    BMJ. 2005 Nov 5;331(7524):1057. Epub 2005 Oct 10. Erratum in: BMJ. 2005 Dec 3;331(7528):1330. 
  15. Fitzmaurice DA, Hobbs FD, Murray ET, Holder RL, Allan TF, Rose PE.
    Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial.
    Arch Intern Med. 2000 Aug 14-28;160(15):2343-8.
  16. Kortke H, Korfer R.
    International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?
    Ann Thorac Surg. 2001 Jul;72(1):44-8.
  17. Menendez-Jandula B, Souto JC, Oliver A, Montserrat I, Quintana M, Gich I, Bonfill X, Fontcuberta J.
    Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial.
    Ann Intern Med. 2005 Jan 4;142(1):1-10. Summary for patients in: Ann Intern Med. 2005 Jan 4;142(1):I14.
  18. Christensen TD, Andersen NT, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM.
    Mechanical heart valve patients can manage oral anticoagulant therapy themselves.
    Eur J Cardiothorac Surg. 2003 Mar;23(3):292-8.  
  19. Sidhu P, O'Kane HO.
    Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients.
    Ann Thorac Surg. 2001 Nov;72(5):1523-7.
  20. Ansell J, Jacobson A, Levy J, Voller H, Hasenkam JM; International Self-Monitoring Association for Oral Anticoagulation.
    Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation.
    Int J Cardiol. 2005 Mar 10;99(1):37-45.  

Full biography

  1. Deep venous thrombosis and thromboembolism in patients with cervical spinal cord injuries. Neurosurgery 2002 03; 50(3 Suppl):S73-80
  2. Tinzaparin: new indication. Easier treatment of less severe pulmonary embolism. Prescrire Int 2002 02; 11(57):13-5. 2003 07; 
  3.  Patient self-management of oral anticoagulation. Clin Lab Haematol 2002 12; 24(6):391-
  4. Ahmadi R,Schillinger M,Maca T,Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 2002 05; 223(2):345-50
  5. Ahmed S,Karim A,Patel D,Siddiqui R,Mattana J. Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome. Am J Med Sci 2002 11; 324(5):279-80
  6. Al-Lawati AA,Venkitraman M,Al-Delaime T,Valliathu J. Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. Eur J Cardiothorac Surg 2002 08; 22(2):223-7
  7. Albisetti M,Andrew M. Low molecular weight heparin in children. Eur J Pediatr 2002 02; 161(2):71-7
  8. Alonso-Perez M,Segura RJ,Vidal ED. Thrombosed aneurysm of the infrarenal vena cava: diagnosis and treatment. J Cardiovasc Surg (Torino) 2002 08; 43(4):507-10
  9. Ansell JE,Patel N,Ostrovsky D,Nozzolillo E,Peterson AM,Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995 11; 155(20):2185-9
  10. Ansell JE,Buttaro ML,Thomas OV,Knowlton CH. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force. Ann Pharmacother 1997 05; 31(5):604-15
  11. Ansell JE. Empowering patients to monitor and manage oral anticoagulation therapy. JAMA 1999 01; 281(2):182-3
  12. Ansell JE. Patient self-testing and patient self-management of oral anticoagulation: is it too late? Isr Med Assoc J 2002 11; 4(11):1035-6
  13. Ansell JE,Weitz JI,Comerota AJ. Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism. Hematology (Am Soc Hematol Educ Program) 2000 01; :266-284
  14. Aoyagi S,Nishimi M,Tayama E,Fukunaga S,Hayashida N,Akashi H,Kawara T. Obstruction of St Jude medical valves in the aortic position: a consideration for pathogenic mechanism of prosthetic valve obstruction. Cardiovasc Surg 2002 08; 10(4):339-44
  15. Arnold M,Nedeltchev K,Mattle HP. [Anticoagulation and antiaggregation in neurological patients] Ther Umsch 2003 01; 60(1):33-5
  16. Arrojo Arias,Mora Navarro,Abon Santos,Araujo Luis,Capdevila Gallego,Gutierrez Torres. [Oral anticoagulation treatment in patients with non-valvular auricular fibrillation] Aten Primaria 2002 09; 30(5):284-9
  17. August C,Atzeni A,Koster L,Heidenreich S,Lang D. Acute renal failure in IgA nephropathy: aggravation by gross hematuria due to anticoagulant treatment. J Nephrol 2002 11; 15(6):709-12
  18. Barcellona D,Contu P,Marongiu F. Patient education and oral anticoagulant therapy. Haematologica 2002 10; 87(10):1081-6
  19. Bauersachs RM,Lindhoff-Last E,Ehrly AM. [Ambulatory treatment of an acute pulmonary artery embolism in fresh thigh vein thrombosis using low-molecular-weight heparin] Dtsch Med Wochenschr 1999 12; 124(49):1485-8
  20. Baumgartner RW,Georgiadis D. [Secondary prevention after ischemic stroke] Schweiz Rundsch Med Prax 2003 01; 92(5):168-78
  21. Baumgartner RW,Studer A,Arnold M,Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry 2003 04; 74(4):459-61
  22. Bertomeu Martinez,Morillas Blasco,Gonzalez Juanatey,Alegria Ezquerra,Garcia Acuna,Gonzalez Maqueda,Frutos Garcia,Valero Parra,Rodriguez Ortega. [Antithrombotic treatment in hypertensive patients with chronic atrial fibrillation. CARDIOTENS 99 study] Med Clin (Barc) 2002 03; 118(9):327-31
  23. Bhavnani M,Shiach CR. Patient self-management of oral anticoagulation. Clin Lab Haematol 2002 08; 24(4):253-7
  24. Biasiutti FD,Strebel JK. [Anticoagulation and antiaggregation during pregnancy] Ther Umsch 2003 01; 60(1):54-8
  25. Blann AD,Fitzmaurice DA,Lip GY. Anticoagulation in hospitals and general practice. BMJ 2003 01; 326(7381):153-6
  26. Bridges GG,Lee MD,Jenkins JK,Stephens MA,Croce MA,Fabian TC. Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program. J Trauma 2003 02; 54(2):232-5
  27. Brouwer MA,Verheugt FW. Oral anticoagulation for acute coronary syndromes. Circulation 2002 03; 105(11):1270-4
  28. Caldera A,Mora J,Kotler M,Eiger G. Pulmonary embolism in a patient with pernicious anemia and hyperhomocysteinemia. Chest 2002 10; 122(4):1487-8
  29. Caliezi C,Niederer A,Wuillemin WA. [Patient self-management of oral anticoagulation] Ther Umsch 2003 01; 60(1):59-62
  30. Caliezi C,Waber M,Pfiffner D,Saner H,Lammle B,Wuillemin WA. [Patient self-monitoring of oral anticoagulation with CoaguChek] Schweiz Med Wochenschr 2000 06; 130(24):916-23
  31. Calvo Romero,Bureo Dacal,Ramos Salado,Bureo Dacal,Perez Miranda. [Primary antiphospholipid syndrome: characteristics and course of a series of 17 cases] An Med Interna 2002 05; 19(5):226-9
  32. Chandy T,Rao GH,Wilson RF,Das GS. Delivery of LMW heparin via surface coated chitosan/peg-alginate microspheres prevents thrombosis. Drug Deliv 2002 04; 9(2):87-96
  33. Christensen TD,Attermann J,Hjortdal VE,Maegaard M,Hasenkam JM. [Self-management of oral anticoagulant therapy in children with congenital heart defects] Ugeskr Laeger 2002 09; 164(36):4173-7
  34. Christensen TD,Attermann J,Hjortdal VE,Maegaard M,Hasenkam JM. Self-management of oral anticoagulation in children with congenital heart disease. Cardiol Young 2001 05; 11(3):269-76
  35. Christensen TD,Attermann J,Hjortdal VE,Maegaard M,Hasenkam JM. [Self-management of oral anticoagulant therapy in children with congenital heart defects] Ugeskr Laeger 2002 09; 164(36):4173-7
  36. Cosmi B,Palareti G,Carpanedo M,Pengo V,Biasiolo A,Rampazzo P,Morstabilini G,Testa S. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK). Haematologica 2000 08; 85(8):826-31
  37. Crombe D,Pringot J,Van Isveldt,Van Campenhoudt. Thumbprinting due to ischemic colitis in a patient on oral anticoagulation. JBR-BTR 2002 08; 85(4):220-
  38. Cromheecke ME,Levi M,Colly LP,de Mol,Prins MH,Hutten BA,Mak R,Keyzers KC,Buller HR. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000 07; 356(9224):97-102
  39. De Lorenzo,Saba N,Kakkar VV. Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention. Drugs 2003 01; 63(6):565-76
  40. Di Pasquale,Biancoli S,Sassone B,Pancaldi LG. [Atrial fibrillation: always cardioversion? No] Ital Heart J 2002 01; 3(1 Suppl):81-90
  41. Dorffler-Melly J,Schmidli J,Mahler F. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases] Ther Umsch 2003 01; 60(1):36-42
  42. Dunn AS,Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003 04; 163(8):901-8
  43. Eckman MH,Singh SK,Erban JK,Kao G. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis. Med Decis Making 2002 03; 22(2):108-24
  44. Eichinger S,Weltermann A,Mannhalter C,Minar E,Bialonczyk C,Hirschl M,Schonauer V,Lechner K,Kyrle PA. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Arch Intern Med 2002 11; 162(20):2357-60
  45. Emmerich J. [Thrombosis and antithrombotic agents in peripheral artery disease] Arch Mal Coeur Vaiss 2002 11; 95 Spec No 7:59-62
  46. Eriksson M,Christensen K,Lindahl TL,Larsson A. Pharmaceutical thrombosis prevention in cardiovascular disease. Expert Opin Investig Drugs 2002 04; 11(4):553-63
  47. Evans IL,Sayers MS,Gibbons AJ,Price G,Snooks H,Sugar AW. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxillofac Surg 2002 06; 40(3):248-52
  48. Ezekowitz MD,Netrebko PI. Anticoagulation in management of atrial fibrillation. Curr Opin Cardiol 2003 01; 18(1):26-31
  49. Fah F,Zimmerli W,Jordi M,Schoenenberger RA. Septic deep venous thrombosis in intravenous drug users. Swiss Med Wkly 2002 07; 132(27-28):386-92
  50. Fasey N,Brennan PJ,Meade TW. Thrombosis prevention trial: follow-up study of practical implications. Br J Gen Pract 2002 03; 52(476):208-9
  51. Fenyvesi T,Joerg I,Harenberg J. Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation. Clin Chem 2002 10; 48(10):1791-4
  52. Ferreira CN,Vieira LM,Dusse LM,Amaral CF,de Magalhaes,Fenelon LM,das Gracas. Evaluation of the marker of hypercoagulability prothrombin fragment F 1+2 in patients with mechanical or biological heart valve prostheses. Arq Bras Cardiol 2002 11; 79(5):501-9
  53. Ferro JM. Brain embolism - Answers to practical questions. J Neurol 2003 02; 250(2):139-47
  54. Finsterer J,Stollberger C,Hopmeier P. Home-made anticoagulation monitor vs. CoaguCheck-Plus monitoring of oral anticoagulation. Thromb Res 2000 06; 98(6):571-5
  55. Fitzmaurice DA,Murray ET,Gee KM,Allan TF,Hobbs FD. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol 2002 11; 55(11):845-9
  56. Fitzmaurice DA,Murray ET,Hobbs FD. Self-management of oral anticoagulation. Lancet 2000 10; 356(9239):1437-
  57. Fitzmaurice DA,Kesteven P,Gee KM,Murray ET,McManus R. A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation. J Clin Pathol 2003 01; 56(1):48-51
  58. Fitzmaurice DA,Machin SJ. Recommendations for patients undertaking self management of oral anticoagulation. BMJ 2001 10; 323(7319):985-9
  59. Freixa R,Blanch P,Ibernon M,Padro J,Delso J,Sobrepera JL,Salas E,Dos L,Codinach P. [Identification of factors responsible for oral over-anticoagulation in outpatients with heart disease] Rev Esp Cardiol 2003 01; 56(1):65-72
  60. Froom P,Hermoni D,Barak M. [Oral anticoagulation treatment--control, risks, benefits, and informed consent] Harefuah 2003 01; 142(1):56-60, 77
  61. Frost L,Johnsen SP,Pedersen L,Toft E,Husted S,Sorensen HT. Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice. J Intern Med 2002 07; 252(1):64-9
  62. Fukuda T,Yokoyama T,Otaki M,Oku H,Shiina M,Umemoto M. Successful planned pregnancy in a patient with St Jude medical prosthetic mitral valve. Circ J 2002 02; 66(2):204-6
  63. Gadisseur AP,van der,Adriaansen HJ,Fihn SD,Rosendaal FR. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br J Haematol 2002 06; 117(4):940-6
  64. Garachemani AR,Fleisch M,Windecker S,Pfiffner D,Meier B. Heparin and coumadin versus acetylsalicylic acid for prevention of restenosis after coronary angioplasty. Catheter Cardiovasc Interv 2002 03; 55(3):315-20
  65. Ghofrani HA,Olschewski H,Seeger W,Grimminger F. [Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure] Pneumologie 2002 11; 56(11):665-72
  66. Gibbons AJ,Sugar AW. Oral anticoagulation and dental extractions. Br J Haematol 2002 12; 119(4):1137-
  67. Gill S,Naiman SC,Jamal A,Vickars LM. Massive bleeding on a bladder protectant: a case report of pentosan polysulfate sodium-induced coagulopathy. Arch Intern Med 2002 07; 162(14):1644-5
  68. Gohlke-Barwolf C. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses] Z Kardiol 2001 01; 90 Suppl 6:112-7
  69. Gokterin O,Uzener N,Ata N,Kudaiberdieva G,Gucuyener D,Ozdemir G,Timuralp B. Does short-term anticoagulation with heparin increase risk for microemboli patients undergoing transesophageal guided electrical cardioversion for atrial fibrillation? A transcranial Doppler ultrasonography study. Int J Cardiol 2003 03; 88(1):107-12
  70. Gras-Champel V,Pannier M,Tellier V,Voyer A,Roussel B,Masson H,Jeanjean P,Montpellier D,Canaple S,Toussaint P,Andrejak M. [Intracranial hemorrhages associated with oral anticoagulant therapy. Analysis of 38 cases] Therapie 2002 05; 57(3):297-301
  71. Green RM. The role of prophylactic anticoagulation in the surgical patient. Curr Probl Surg 2003 02; 40(2):92-130
  72. Gronbaek H,Nielsen DT,Astrup LB. [Budd-Chiari syndrome illustrated by four case reports] Ugeskr Laeger 2002 06; 164(25):3360-3
  73. Gunther T,Mazzitelli D,Schreiber C,Wottke M,Paek SU,Meisner H,Lange R. Mitral-valve replacement in children under 6 years of age. Eur J Cardiothorac Surg 2000 04; 17(4):426-30
  74. Harenberg J,Ingrid J,Tivadar F. Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran. Isr Med Assoc J 2002 11; 4(11):1003-5
  75. Harenberg J,Fenyvesi T,Jorg I. [Ximelagatran for treatment of venous thromboembolism] Hamostaseologie 2002 08; 22(3):25-9
  76. Hasenkam JM,Kimose HH,Knudsen L,Gronnesby H,Halborg J,Christensen TD,Attermann J,Pilegaard HK. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997 05; 11(5):935-42
  77. Hata N,Tanaka K,Imaizumi T,Ohba T,Ohara T,Shinada T,Yokoyama S,Makino T,Takano T. Prognosis of economy class syndrome treated in intensive care unit. Intern Med 2002 02; 41(2):91-4
  78. Hauptmann J. Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs. A review of small-molecule thrombin inhibitors. Eur J Clin Pharmacol 2002 01; 57(11):751-8
  79. Hegenbarth K,Fickert P,Aschauer M,Horina JH,Stauber RE,Trauner M. Successful management of acute portal vein thrombosis by low molecular weight heparin and oral anticoagulation. Am J Gastroenterol 2002 06; 97(6):1567-8
  80. Heidinger KS,Bernardo A,Taborski U,Muller-Berghaus G. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis. Thromb Res 2000 05; 98(4):287-93
  81. Herion F,David JL,Boxho P,Rompen E. [Anti-vitamins K and oral surgery: the end of their prohibition?] Rev Med Liege 2002 05; 57(5):330-3
  82. Hernandez F,Pombo M,Dalmau R,Andreu J,Alonso M,Albarran A,Velazquez MT,Tascon JC. Acute coronary embolism: angiographic diagnosis and treatment with primary angioplasty. Catheter Cardiovasc Interv 2002 04; 55(4):491-4
  83. Heuer L,Blumenberg D. [Recombinant factor VIIa (NovoSeven). A review of current and possible future indications] Anaesthesist 2002 05; 51(5):388-99
  84. Hochreiter WW,Thalmann GN,Burkhard FC,Studer UE. Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 2002 10; 168(4 Pt 1):1470-4
  85. Horstkotte D,Piper C,Wiemer M. Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease. J Thromb Thrombolysis 1998 01; 5 Suppl 1(3):19-24
  86. Huber J,Stollberger C,Finsterer J,Schneider B,Langer T. Quality of blood pressure control and risk of cerebral bleeding in patients with oral anticoagulation. Acta Med Austriaca 2003 01; 30(1):6-9
  87. Hunt BJ,Khamashta MA. Intensity and duration of oral anticoagulation in antiphospholipid antibody associated thrombosis. J Rheumatol 2002 11; 29(11):2468; author reply 2468-70
  88. Jung F,Miesbach W,Scharrer I. [Cardiac and cerebral manifestations of antiphospholipid syndrome] Z Kardiol 2002 08; 91(8):650-8
  89. Kaboli P,Henderson MC,White RH. DVT prophylaxis and anticoagulation in the surgical patient. Med Clin North Am 2003 01; 87(1):77-110, viii
  90. Kahn SR,Ginsberg JS. The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev 2002 09; 16(3):155-65
  91. Kearon C. Duration of therapy for acute venous thromboembolism. Clin Chest Med 2003 03; 24(1):63-72
  92. Keeling DM. Rebuttal--a prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000 11; 84(5):931-2
  93. Kemkes-Matthes B,Matzdorff A,Heidt M,Winkler L,Bernardo A,Bernardo A. [Initiation of oral anticoagulant treatment: comparison between different dosage regimens of warfarin and phenprocoumon] Hamostaseologie 2002 05; 22(2):47-51
  94. King AB,Lemaire GJ. Managing anticoagulation in patients with atrial fibrillation. Nurse Pract 2002 09; 27(9):17-8, 21
  95. Klein L,Gattis WA,Zampino M,de Luca,Vitarelli A,Fedele F,Gheorghiade M. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol 2003 05; 91(9A):18F-40F
  96. Kortke H,Minami K,Breymann T,Seifert D,Baraktaris A,Wagner O,Kleikamp G,el-Banayosy A,Mirow N,Korfer R. [INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial)] Z Kardiol 2001 01; 90 Suppl 6:118-24
  97. Kortke H,Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001 07; 72(1):44-8
  98. Kovacs MJ,Anderson DA,Wells PS. Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism. Pathophysiol Haemost Thromb 2002 05; 32(3):131-3
  99. Kovacs MJ,Rodger M,Anderson DR,Morrow B,Kells G,Kovacs J,Boyle E,Wells PS. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial. Ann Intern Med 2003 05; 138(9):714-9
  100. Kuhne T. [Anticoagulation and antiaggregation in pediatrics] Ther Umsch 2003 01; 60(1):49-53
  101. Kulinna W,Ney D,Wenzel T,Heene DL,Harenberg J. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thromb Hemost 1999 01; 25(1):123-6
  102. Kyrle PA,Eichinger S. The risk of recurrent venous thromboembolism. Vasa 2002 08; 31(3):163-6
  103. Lammle B. [Clinical problems with oral anticoagulation -- 3 case reports] Ther Umsch 2003 01; 60(1):63-6
  104. Langer F,Eifrig B,Hegewisch-Becker S,Marx G,Neuber K,Hossfeld DK. [Complicated antiphospholid antibody syndrome] Dtsch Med Wochenschr 2002 07; 127(27):1458-62
  105. Leaning KE,Ansell JE. Advances in the Monitoring of Oral Anticoagulation: Point-of-Care Testing, Patient Self-Monitoring, and Patient Self-Management. J Thromb Thrombolysis 1996 01; 3(4):377-383
  106. Lehrman S,Romano P,Frishman W,Rashid A,Dobkin J,Reichel J. Primary pulmonary hypertension and cor pulmonale. Cardiol Rev 2002 09; 10(5):265-78
  107. Lewandowski B. [Topical treatment of bleeding post removed teeth in patients with prosthetic heart valves whose receiving long-term of oral anticoagulant therapy] Pol Merkuriusz Lek 2002 01; 12(67):20-4
  108. Leyh RG,Fischer S,Ruhparwar A,Haverich A. Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg 2002 03; 21(3):577-9
  109. Leyh RG,Fischer S,Ruhparwar A,Haverich A. [Anticoagulation in pregnant women after artificial heart valve replacement: is low-molecular-weight heparin an alternative?] Z Kardiol 2002 04; 91(4):297-303
  110. Li Q,Tosiello L. Patient self-management of oral anticoagulation. JAMA 1999 06; 281(24):2283-4
  111. Lindhoff-Last E,Humpich M,Schmitt J,Rodiger S,Seifried E,Bauersachs R. MIXCON-LA: a precise, sensitive and specific aPTT-based assay for detection of lupus anticoagulant. Clin Appl Thromb Hemost 2002 04; 8(2):163-7
  112. Lip GY,Gibbs CR. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM 2002 07; 95(7):451-9
  113. Lip GY,Gibbs CR. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM 2002 07; 95(7):461-8
  114. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002 02; 99(2):333-41
  115. Lubenow N,Selleng S,Wollert HG,Eichler P,Mullejans B,Greinacher A. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use. Ann Thorac Surg 2003 02; 75(2):577-9
  116. Lund F,Qian Z,Schiotz J,Tillgren C. Limb salvage instead of amputation in 10 cases of nonreconstructible "end-point ischemia" treated with i.v. hydroxyethylrutosides plus oral anticoagulation. Angiology 2002 07; 53(4):391-8
  117. Mahesh B,Evans S,Bryan AJ. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: case report and a review of options for anticoagulation. J Heart Valve Dis 2002 09; 11(5):745-50
  118. Marbet GA. [Heparins] Ther Umsch 2003 01; 60(1):10-3
  119. Martinez Rubio,Moreno Lopez,Lama M,Sanchez Bielsa. [Primary antiphospholipid syndrome diagnosed in hemodialysis] Nefrologia 2002 01; 22(1):71-4
  120. Matsuyama K,Matsumoto M,Sugita T,Nishizawa J,Yoshida K,Tokuda Y,Matsuo T. Anticoagulant therapy in Japanese patients with mechanical mitral valves. Circ J 2002 07; 66(7):668-70
  121. Merchan A,Lopez-Minguez JR,Alonso F,Fernandez De,Gonzalez R,Martinez De. [Giant left main coronary aneurysm without associated coronary lesions] Rev Esp Cardiol 2002 03; 55(3):308-11
  122. Morrissey PE,Ramirez PJ,Gohh RY,Yango AY,Kestin A,Madras PN,Monaco AP. Management of thrombophilia in renal transplant patients. Am J Transplant 2002 10; 2(9):872-6
  123. Morsdorf S,Erdlenbruch W,Taborski U,Schenk JF,Erdlenbruch K,Novotny-Reichert G,Krischek B,Wenzel E. Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspects. Semin Thromb Hemost 1999 01; 25(1):109-15
  124. Moser D,Rasse M,Schopper C,Lagogiannis G,Frass M,Ewers R,Kaye AD,Hofbauer R. A scanning electron microscopic study on thrombogenicity of intraarterial catheters for chemotherapeutic treatment in head and neck cancer. Head Neck 2002 06; 24(6):566-74
  125. Mueller-Kolck U. Long-term oral anticoagulation therapy of peripheral arterial disease. Vasa 2001 05; 30(2):83-8
  126. Muller I,Massberg S,Zierhut W,Binz C,Schuster A,Rudiger-von Hoch,Braun S,Gawaz M. Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol Haemost Thromb 2002 01; 32(1):16-24
  127. Muthukrishnan A. Re: Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000; 38: 124-126. Br J Oral Maxillofac Surg 2002 06; 40(3):266-
  128. Nedeltchev K,Arnold M,Wahl A,Sturzenegger M,Vella EE,Windecker S,Meier B,Mattle HP. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 2002 03; 72(3):347-50
  129. Niederer A,Wuillemin WA. [Therapy of venous thromboembolism] Schweiz Rundsch Med Prax 2001 02; 90(6):213-9
  130. Nowatzke WL,Landt M,Smith C,Wilhite T,Canter C,Luchtman-Jones L. Whole blood international normalization ratio measurements in children using near-patient monitors. J Pediatr Hematol Oncol 2003 01; 25(1):33-7
  131. Oden A,Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002 11; 325(7372):1073-5
  132. Palareti G,Legnani C,Cosmi B,Guazzaloca G,Pancani C,Coccheri S. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002 01; 87(1):7-12
  133. Paliani U,Filippucci E,Gresele P. Significant potentiation of anticoagulation by flu-vaccine during the season 2001-2002. Haematologica 2003 05; 88(5):599-600
  134. Paliani U,Filippucci E,Gresele P. Significant potentiation of anticoagulation by flu-vaccine during the season 2001-2002. Haematologica 2003 05; 88(5):599-600
  135. Paramo JC,Sendzischew H,Sivina M. Comparison of the use of enoxaparin versus unfractionated heparin in patients undergoing lower extremity revascularization. Vasc Endovascular Surg 2002 05; 36(3):199-205
  136. Pass SE,Dusing ML. Current and emerging therapy for primary pulmonary hypertension. Ann Pharmacother 2002 09; 36(9):1414-23
  137. Patel MR,Roe MT. Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation. Drugs Aging 2002 01; 19(9):633-46
  138. Perez Gomez,Lourenzo PI,Companion J,Escriba A,Perez Saldana,Guillen M,Vargas E,S-Harguindey L. Platelet aggregation in different antithrombotic regimens. Possible proaggregant effect of low level oral anticoagulation. Rev Port Cardiol 2002 05; 21(5):541-51
  139. Pinede L. [Duration of oral anticoagulant therapy in deep venous thrombosis of the lower limbs] Ann Cardiol Angeiol (Paris) 2002 06; 51(3):158-63
  140. Piso B,Jimenz-Boj E,Krinninger B,Watzke HH. The quality of oral anticoagulation before, during and after a period of patient self-management. Thromb Res 2002 04; 106(2):101-4
  141. Piso B,Jimenz-Boj E,Krinninger B,Watzke HH. The quality of oral anticoagulation before, during and after a period of patient self-management. Thromb Res 2002 04; 106(2):101-4
  142. Poli D,Antonucci E,Lombardi A,Gensini GF,Abbate R,Prisco D. Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation. Haematologica 2003 02; 88(2):237-8
  143. Poller L,Keown M,Chauhan N,van den,Meeuwisse-Braun J,Tripodi A,Clerici M,Jespersen J. European concerted action on anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors. Clin Chem 2002 02; 48(2):255-60
  144. Prandoni P,Bruchi O,Sabbion P,Tanduo C,Scudeller A,Sardella C,Errigo G,Pietrobelli F,Maso G,Girolami A. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med 2002 09; 162(17):1966-71
  145. Preston FE,Laidlaw ST,Sampson B,Kitchen S. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002 03; 116(3):619-24
  146. Rodrigues HL,Brandao ES,Lima BS. Update of the management of venous thromboembolism. Rev Port Cardiol 2002 02; 21(2):183-99
  147. Roubey RA. Treatment of the antiphospholipid syndrome. Curr Opin Rheumatol 2002 05; 14(3):238-42
  148. Schimpf T,Stellbrink C. [Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future] Med Klin 2003 02; 98(2):91-5
  149. Schonauer V,Kyrle PA,Weltermann A,Minar E,Bialonczyk C,Hirschl M,Quehenberger P,Schneider B,Partsch H,Eichinger S. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg 2003 04; 37(4):834-8
  150. Schuchert A,Meinertz T. [Prevention of arterial thromboembolisms in patients with atrial fibrillation] Herz 2002 06; 27(4):322-8
  151. Schupfner B,Osterziel K,Hohenberger P. [Aneurysm of the popliteal vein causing pulmonary thromboembolism that required resuscitation] Dtsch Med Wochenschr 2002 06; 127(24):1312-6
  152. Seipelt RG,Franke A,Vazquez-Jimenez JF,Hanrath P,von Bernuth,Messmer BJ,Muhler EG. Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. Ann Thorac Surg 2002 08; 74(2):556-62
  153. Silaruks S,Thinkhamrop B,Tantikosum W,Wongvipaporn C,Tatsanavivat P,Klungboonkrong V. A prognostic model for predicting the disappearance of left atrial thrombi among candidates for percutaneous transvenous mitral commissurotomy. J Am Coll Cardiol 2002 03; 39(5):886-91
  154. Silaruks S,Kiatchoosakun S,Tantikosum W,Wongvipaporn C,Tatsanavivat P,Klungboonkrong V,Thinkhamrop B. Resolution of left atrial thrombi with anticoagulant therapy in candidates for percutaneous transvenous mitral commissurotomy. J Heart Valve Dis 2002 05; 11(3):346-52
  155. Simmelink MJ,de Groot,Derksen RH,Fernandez JA,Griffin JH. Oral anticoagulation reduces activated protein C less than protein C and other vitamin K-dependent clotting factors. Blood 2002 12; 100(12):4232-3
  156. Sitbon O,Humbert M,Simonneau G. Primary pulmonary hypertension: Current therapy. Prog Cardiovasc Dis 2002 09; 45(2):115-28
  157. Stahle E. Mechanical valve anticoagulation--between Scylla and Charybdis. Scand Cardiovasc J 2001 03; 35(2):69-71
  158. Stellbrink C,Hanrath P,Nixdorff U,Hofmann T,Lehmacher W,Kuhle K,Fetsch T,Grewe R,Schmidt-Lucke JA. Low molecular weight heparin for prevention of thromboembolic complications in cardioversion--rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin). Z Kardiol 2002 03; 91(3):249-54
  159. Stollberger C,Finsterer J,Ernst G,Schneider B. Is left atrial appendage occlusion useful for prevention of stroke or embolism in atrial fibrillation? Z Kardiol 2002 05; 91(5):376-9
  160. Stollberger C,Schneider B,Finsterer J. Is percutaneous left atrial appendage transcatheter occlusion an alternative to oral anticoagulation in patients with atrial fibrillation? Circulation 2003 01; 107(1):e11-2; author reply e11
  161. Stolz E,Gerriets T,Bodeker RH,Hugens-Penzel M,Kaps M. Intracranial venous hemodynamics is a factor related to a favorable outcome in cerebral venous thrombosis. Stroke 2002 06; 33(6):1645-50
  162. Strandberg M,Marttila RJ,Helenius H,Hartiala J. Transoesophageal echocardiography in selecting patients for anticoagulation after ischaemic stroke or transient ischaemic attack. J Neurol Neurosurg Psychiatry 2002 07; 73(1):29-33
  163. Sunderji R,Campbell L,Shalansky K,Fung A,Carter C,Gin K. Outpatient self-management of warfarin therapy: a pilot study. Pharmacotherapy 1999 06; 19(6):787-93
  164. Taborski U,Muller-Berghaus G. State-of-the-art patient self-management for control of oral anticoagulation. Semin Thromb Hemost 1999 01; 25(1):43-7
  165. Tay MH,Tien SL,Chua TS,Sim LL,Koh TH. An evaluation of point-of-care instrument for monitoring anticoagulation level in adult cardiac patients. Singapore Med J 2002 11; 43(11):557-62
  166. Turk EE,Verhoff MA,Tsokos M. Anticoagulant-related iliopsoas muscle bleeding leading to fatal exsanguination: report of two autopsy cases. Am J Forensic Med Pathol 2002 12; 23(4):342-4
  167. Undas A,Bazan-Socha S,Swadzba J,Musial J. Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report. Blood Coagul Fibrinolysis 2002 01; 13(1):53-6
  168. Vacas M,Lafuente PJ,Cuesta S,Iriarte JA. Comparative study of a portable monitor for prothrombin time determination, Coaguchek, with three systems for control of oral anticoagulant treatment. Haemostasis 1998 11; 28(6):321-8
  169. Vazquez E,Sanchez-Perales C,Garcia-Cortes MJ,Borrego F,Lozano C,Guzman M,Gil JM,Liebana A,Perez P,Borrego MJ,Perez V. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int J Cardiol 2003 02; 87(2-3):135-9; discussion 139
  170. Veloso HH,De Paola. Atrial fibrillation or flutter and stroke: effectiveness of oral anticoagulation in clinical practice. J Intern Med 2003 01; 253(1):92-3
  171. Verheugt FW. [Cardioversion for atrial fibrillations: not better than ventricular rate control] Ned Tijdschr Geneeskd 2003 04; 147(14):636-8
  172. Vetter Ch. [Anticoagulation: the present and the future] Hamostaseologie 2002 08; 22(3):15-20
  173. Voller H,Glatz J,Taborski U,Bernardo A,Dovifat C,Burkard G,Heidinger K. [Background and evaluation plan of a study on self-management of anticoagulation in patients with non-valvular atrial fibrillation (SMAAF Study)] Z Kardiol 2000 04; 89(4):284-8
  174. Vucic N,Ostojic R,Svircic T. Treatment of deep vein thrombosis with oral anticoagulants in patients with malignancy: prospective cohort study. Croat Med J 2002 06; 43(3):296-300
  175. Watzke HH,Forberg E,Svolba G,Jimenez-Boj E,Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000 05; 83(5):661-5
  176. Wenzel T,Morsdorf S,Sibitz I,Schenck JF,Griengl H,Erdlenbruch W,Heinrich W,Krischek B,Birner P,Harenberg J. Dimensions of quality of life and self-monitoring therapy with oral anticoagulants--still research or everyday practice? Semin Thromb Hemost 1999 01; 25(1):117-21
  177. White RH,McBurnie MA,Manolio T,Furberg CD,Gardin JM,Kittner SJ,Bovill E,Knepper L. Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med 1999 02; 106(2):165-71
  178. White RH,McCurdy SA,von Marensdorff,Woodruff DE,Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med 1989 11; 111(9):730-7
  179. de Luca,Sorino M,Del Salvatore,de Luca. A new therapeutic strategy for electrical cardioversion of atrial fibrillation. Ital Heart J 2001 11; 2(11):831-40
  180. van Walraven,Hart RG,Wells GA,Petersen P,Koudstaal PJ,Gullov AL,Hellemons BS,Koefed BG,Laupacis A. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003 04; 163(8):936-43
  181. van Es,Jonker JJ,Verheugt FW,Deckers JW,Grobbee DE. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 2002 07; 360(9327):109-13
  182. van den,Geven LM,Kuitert NA,Risselada A,Brouwers JR. The potential interaction between oral anticoagulants and acetaminophen in everyday practice. Pharm World Sci 2002 10; 24(5):201-4

 

 

  
Print Top